JNJ-7184, a respiratory syncytial virus inhibitor targeting the connector domain of the viral polymerase-Reference-Cited by-同舟云学术

JNJ-7184, a respiratory syncytial virus inhibitor targeting the connector domain of the viral polymerase

Published:2024-07 Issue: Volume:227 Page:105907
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Bonneux Brecht^ORCID,Shareef Afzaal^ORCID,Tcherniuk Sergey^ORCID,Anson Brandon^ORCID,de Bruyn Suzanne^ORCID,Verheyen Nick,Thys Kim,Conceição-Neto Nádia^ORCID,Van Ginderen Marcia,Kwanten Leen,Ysebaert Nina^ORCID,Vranckx Luc,Peeters Elien,Lanckacker Ellen,Gallup Jack M.,Sitthicharoenchai Panchan,Alnajjar Sarhad^ORCID,Ackermann Mark R.,Adhikary Suraj,Bhaumik Anusarka^ORCID,Patrick Aaron^ORCID,Fung Amy,Sutto-Ortiz Priscila^ORCID,Decroly Etienne,Mason Stephen W.^ORCID,Lançois David^ORCID,Deval Jerome,Jin Zhinan,Eléouët Jean-François,Fearns Rachel,Koul Anil,Roymans Dirk,Rigaux Peter,Herschke Florence^ORCID

Funder

Johnson and Johnson

Agentschap Innoveren en Ondernemen

Publisher

Elsevier BV

Reference41 articles.

1. Structure and functional analysis of the RNA- and viral phosphoprotein-binding domain of respiratory syncytial virus M2-1 protein;Blondot;PLoS Pathog.,2012

2. RNA elongation. by respiratory syncytial virus polymerase is calibrated by conserved region V;Braun;PLoS Pathog.,2017

3. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter;Buchholz;J. Virol.,1999

4. Chapter 10: respiratory syncytial virus and metapneumovirus in fields virology;Buchholz,2022

5. A phase 2, randomized, double-blind, placebo-controlled trial of presatovir for the treatment of respiratory syncytial virus upper respiratory tract infection in hematopoietic-cell transplant recipients;Chemaly;Clin. Infect. Dis.,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct-acting antivirals for RSV treatment, a review;Antiviral Research;2024-09

2. Recent Progress toward the Discovery of Small Molecules as Novel Anti-Respiratory Syncytial Virus Agents;Journal of Medicinal Chemistry;2024-07-06